Women face health conditions that disproportionately, differently, or uniquely affect them – yet they remain underrepresented and underfunded in research and overlooked in healthcare. Despite making up the majority of patients in diseases like autoimmune disorders, Alzheimer’s, and heart disease, women receive just a fraction of research funding. Only 2% of venture capital and under 11% of government grants are dedicated to women’s health.

Why is there under-investment in research and development of women’s health innovation and why is this so important now more than ever before?

Dial in to find out from the experts:

• Liz Powell, Esq., MPH — Founder, Women’s Health Advocates
• Shruti Valjee — Leader, WHA’s Pittsburgh Chapter
• Maura Rosenfeld — Patient story
• Jocelyn Fitzgerald, MD, FACOG FPMRS — UroGynecology and Pelvic Reconstructive Surgeon, UPMC Magee-Women’s Health and Author, Price and Prejudice: Reimbursement of Surgical Care on Male Versus Female Anatomies
• Mary Ackenbom, MD, MSc — UroGynecologist, Assistant Professor, Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Urogynecology & Reconstructive Pelvic Surgery, UPMC
• Melinda Colaizzi — CEO, Women Who Rock